PSMB8 and obesity due to melanocortin 4 receptor deficiency: The present study not only demonstrates that LMP7 may be a potential therapeutic target for prevention and treatment of obesity and metabolic disorders but also provides new insights into the mechanism underlying the pathophysiology of these disorders.